Skip to main content

Find Clinical Trials

Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,712 public trials 267 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

NCT04959032

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Clinical Site Little Rock, Arkansas, United States

Clinical Site Bellflower, California, United States

Clinical Site Cerritos, California, United States

Clinical Site Culver City, California, United States

View all 43 locations

View Trial Details

Completed

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia

NCT02720263

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Site US10001 Glendale, California, United States

View Trial Details

Completed

A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia

NCT03356639

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Cctmg/Parexel Glendale, California, United States

Community Clinical Research Austin, Texas, United States

View Trial Details

Completed

A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

NCT01527305

Conditions: Mental Disorders, Psychotic Disorders, Schizophrenia, +1 more
Locations: Huzhou, China

Shanghai, China

Shantou, China

Suzhou, China

View all 21 locations

View Trial Details

Completed

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

NCT04659174

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Pillar Clinical Research Bentonville, Arkansas, United States

Woodland International Research Group Little Rock, Arkansas, United States

Advanced Research Center, Inc. Anaheim, California, United States

Advanced Research Center Inc Bellflower, California, United States

View all 44 locations

View Trial Details

Completed

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

NCT01051531

Conditions: Disease, Mental Disorders, Pathologic Processes, +3 more
Locations: Dandenong, Australia

Elizabeth Vale, Australia

Epping, Australia

Frankston, Australia

View all 41 locations

View Trial Details

Completed

Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005

NCT05779241

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations: CenExel CNS Garden Grove, California, United States

Atlanta Center for Medical Research Atlanta, Georgia, United States

Uptown Research Institute Chicago, Illinois, United States

Hassman Research Institute Marlton, New Jersey, United States

View Trial Details

Completed

NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia

NCT06653829

Conditions: Mental Disorders, Negative Symptoms in Schizophrenia, Psychotic Disorders, +3 more
Locations: North Shore Therapeutics, Inc. Rochester, Minnesota, United States

View Trial Details

Completed

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

NCT01029769

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +3 more
Locations: Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar Munich, Bavaria, Germany

View Trial Details

Completed

A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses

NCT04612777

Conditions: Bipolar Disorder, Bipolar and Related Disorders, Depressive Disorder, +6 more
Locations: Not specified

View Trial Details